ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 76 filers reported holding ORCHARD THERAPEUTICS PLC in Q3 2020. The put-call ratio across all filers is 4.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $360,000 | +35.3% | 616,402 | +64.7% | 0.05% | +50.0% |
| Q1 2022 | $266,000 | -40.5% | 374,276 | +10.5% | 0.04% | -35.7% |
| Q4 2021 | $447,000 | -48.1% | 338,756 | -9.6% | 0.06% | -36.4% |
| Q3 2021 | $862,000 | -57.1% | 374,811 | +35.6% | 0.09% | -73.6% |
| Q1 2021 | $2,007,000 | +4263.0% | 276,381 | +2484.0% | 0.33% | +4062.5% |
| Q4 2020 | $46,000 | -2.1% | 10,696 | -5.7% | 0.01% | 0.0% |
| Q3 2020 | $47,000 | -62.1% | 11,347 | -45.2% | 0.01% | -88.4% |
| Q2 2020 | $124,000 | – | 20,707 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 4,081,972 | $9,388,000 | 2.74% |
| RA Capital Management | 11,028,722 | $25,366,000 | 0.35% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $15,984,000 | 0.31% |
| Avidity Partners Management LP | 3,836,798 | $8,825,000 | 0.20% |
| Casdin Capital, LLC | 2,575,000 | $5,923,000 | 0.15% |
| Vivo Capital, LLC | 1,325,736 | $3,049,000 | 0.14% |
| Artal Group S.A. | 1,803,858 | $4,149,000 | 0.09% |
| Eversept Partners, LP | 569,581 | $1,310,036 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 374,811 | $862,000 | 0.09% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,078,315 | $2,480,000 | 0.07% |